Prophylaxis for Meningitis
For meningococcal meningitis prophylaxis, single-dose oral ciprofloxacin 500 mg is the first-line recommendation for adults, with ceftriaxone 250 mg IM or rifampin 600 mg twice daily for 2 days as alternatives. 1, 2
Meningococcal Meningitis Prophylaxis
Who Requires Prophylaxis
- Close contacts must receive prophylaxis within 24 hours of case identification, including household members, intimate kissing contacts, childcare center contacts, and anyone directly exposed to oral secretions. 1
- The risk of meningococcal disease increases 400-800 fold in close contacts, with secondary attack rates of 2-4 per 1000 population. 1, 3
First-Line Antibiotic Regimens
Adults (>16 years):
- Ciprofloxacin 500 mg oral single dose (preferred due to single-dose convenience and high street pharmacy availability) 1, 2
- Ceftriaxone 250 mg IM single dose 1, 2
- Rifampin 600 mg orally twice daily for 2 days 1, 4
Pediatric Dosing:
- Ciprofloxacin: 30 mg/kg for children <5 years; 250 mg for children 5-12 years 3
- Ceftriaxone: 125 mg IM single dose for children <16 years 2, 3
- Rifampin: 5 mg/kg twice daily for 2 days (<1 month); 10 mg/kg twice daily for 2 days (1-12 months and 3 months-12 years); 600 mg twice daily for 2 days (>12 years) 2, 4
Critical Considerations
- Ciprofloxacin is now preferred over rifampin because it requires only a single dose and avoids the emergence of rifampin-resistant isolates that can occur with rifampin use. 1, 5
- Patients who received IV ceftriaxone for treatment do not need additional prophylaxis before discharge. 1
- An increased risk persists for 6 months after exposure, even with prophylaxis; general practice records should be flagged accordingly. 1
Emerging Resistance Concerns
- In areas with ciprofloxacin resistance (≥2 cases with resistant strains AND ≥20% of cases resistant in a 12-month period), preferentially use rifampin, ceftriaxone, or azithromycin instead of ciprofloxacin. 6
Vaccination Considerations
- Contacts of vaccine-preventable non-B serogroups should receive meningococcal vaccination. 1
- After a second confirmed serogroup B case in a household, consider Bexsero vaccination in addition to chemoprophylaxis for all household contacts. 1
Haemophilus influenzae Type B Prophylaxis
Indications for Prophylaxis
- Prophylaxis is required only when households contain an at-risk individual (child <10 years or immunosuppressed person of any age). 1
- All household contacts and the index case should receive rifampin if an at-risk individual is present. 1
Dosing Regimen
- Adults and children >3 months: Rifampin 20 mg/kg once daily (maximum 600 mg) for 4 days 1, 4
- Infants <3 months: Rifampin 10 mg/kg once daily for 4 days 1
Vaccination
- All previously unvaccinated household contacts under age 10 should receive Hib vaccination. 1
Pneumococcal Meningitis
Prophylaxis Not Indicated
- Close contacts of pneumococcal meningitis do NOT require antibiotic prophylaxis, as they are not at increased risk. 1
- Clusters in elderly care homes should be discussed with local health protection authorities. 1
Vaccination Recommendations
- Patients who have had pneumococcal meningitis should receive pneumococcal vaccination to reduce recurrence risk (1-5% recurrence rate). 1
- Vaccination is particularly beneficial for patients with CSF leakage along with surgical repair of the dural barrier. 1
Implementation Pitfalls
- Do not delay prophylaxis—it must be initiated within 24 hours of case identification for maximum effectiveness. 1
- Droplet precautions should continue until contacts have received 24 hours of effective prophylaxis. 2
- Monitor contacts for symptoms for at least 10 days after exposure, even after receiving prophylaxis. 2
- Rifampin causes orange discoloration of body fluids and has multiple drug interactions; counsel patients accordingly. 4
- Ciprofloxacin is safe in pregnancy and all age groups, making it the most practical first-line choice. 1